Change - Announcement of Cessation::CESSATION AS DIRECTOR, TECHNOLOGY AND STRATEGIC DEVELOPMENT OF HMI & CEO OF RSH
Issuer & Securities
HEALTH MANAGEMENT INTERNATIONAL LTD
HEALTH MANAGEMENT INTL LTD - SG1H18874567 - 588
Change - Announcement of Cessation
Date &Time of Broadcast
Announcement Sub Title
CESSATION AS DIRECTOR, TECHNOLOGY AND STRATEGIC DEVELOPMENT OF HMI & CEO OF RSH
Submitted By (Co./ Ind. Name)
Dr Gan See Khem
Executive Chairman and Managing Director
Description (Please provide a detailed description of the event in the box below)
Please refer to the below information.
Name Of Person
Gan Boon San
Is effective date of cessation known?
If yes, please provide the date
Detailed Reason (s) for cessation
Mr Gan Boon San left to pursue other interests.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
Any other relevant information to be provided to shareholders of the listed issuer?
Date of Appointment to current position
Does the AC have a minimum of 3 members (taking into account this cessation)?
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Director, Technology and Strategic Development of Health Management International Ltd and Chief Executive Officer of Regency Specialist Hospital.
Role and responsibilities
Mr Gan Boon San was responsible for providing leadership and strategic direction for use of appropriate technology at HMI subsidiaries or new businesses, and leading the development of Regency Specialist Hospital to become a major regional tertiary care hospital.
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
Shareholding interest in the listed issuer and its subsidiaries?
Past (for the last 5 years)